Inhibition of VAP1: quickly gaining ground as an anti-inflammatory therapy.
Yraola
Francesc
F
Combinatorial Chemistry Unit, Barcelona Science Park, Josep Samitier 1-5, Barcelona, Spain.
Albericio
Fernando
F
Royo
Miriam
M
D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000138:chemical synthesis / Q000627:therapeutic use*; D015815:Cell Adhesion Molecules / Q000037:antagonists & inhibitors*; D002478:Cells, Cultured; D015195:Drug Design; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000201:enzymology; D007962:Leukocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D014469:Umbilical Arteries / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D015815:Cell Adhesion Molecules; C076668:AOC3 protein, human; D006631:Amine Oxidase (Copper-Containing)